- জেনেরিক নাম
- Rivaroxaban
- শক্তি
- 10 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Renata PLC.
ROXOLYTE F.C TABLET Tablet
ROXOLYTE F.C TABLET 10 mg সম্পর্কে
বাংলাদেশে ROXOLYTE F.C TABLET 10 mg ট্যাবলেট হিসেবে পাওয়া যায়; এতে Rivaroxaban আছে (১০ mg)। ROXOLYTE F.C TABLET-এর সাথে Rivaroxaban-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ROXOLYTE F.C TABLET প্রস্তুত করেছে Renata PLC। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Rivaroxaban-এর ১৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Rivadel 2.5 Tablet-এর, প্রতি ইউনিট ৳ ৫।
ROXOLYTE F.C TABLET 10 mg কী?
ROXOLYTE F.C TABLET is a film-coated tablet that contains rivaroxaban 10 mg. Rivaroxaban belongs to a group of medicines called oral anticoagulants, which help reduce the risk of harmful blood clots. It works by blocking a specific clotting factor in the blood. This medicine is available only on prescription, and the doctor decides the right dose and duration for each person. It is important to take it exactly as instructed and not to stop it without medical advice, because stopping suddenly can raise the risk of clots. The pack size and price are not provided here; ask your pharmacist for details.
ROXOLYTE F.C TABLET-এর ব্যবহার
ROXOLYTE F.C TABLET is used in adults to help prevent serious blood clots in conditions such as atrial fibrillation, after certain heart events, or in the treatment of deep vein thrombosis and pulmonary embolism. The doctor will confirm whether it is suitable for you. It is not a painkiller or a general tonic and should not be used for other purposes. Always follow your doctor's advice about why and for how long you need it.
ROXOLYTE F.C TABLET কীভাবে ব্যবহার করবেন
Take ROXOLYTE F.C TABLET by mouth, with or without food, unless your doctor gives different instructions. Swallow the tablet whole with water; do not crush or chew it. The doctor decides the dose, how often to take it, and for how long. Do not change the dose or stop the medicine on your own, even if you feel well, because stopping suddenly can increase the risk of clots. If you miss a dose, ask your doctor or pharmacist what to do.
ROXOLYTE F.C TABLET-এর পার্শ্বপ্রতিক্রিয়া
The most common side effect of rivaroxaban is an increased chance of bleeding. This can include nosebleeds, gum bleeding, easy bruising, or longer bleeding from small cuts. More serious bleeding can occur, including bleeding in the spine or brain, and there is an increased risk of stroke if the medicine is stopped suddenly in people with nonvalvular atrial fibrillation. Seek medical help right away if you have unusual or severe bleeding, black stools, coughing up blood, or a severe headache.
সতর্কতা ও নিরাপত্তা
Before taking ROXOLYTE F.C TABLET, tell your doctor if you have a bleeding disorder, uncontrolled high blood pressure, stomach or bowel disease, eye blood vessel problems, or a history of lung bleeding. Also mention all other medicines you take, including painkillers, blood thinners, or herbal products, as some can raise the risk of bleeding or change how this medicine works. It is not recommended during pregnancy or breastfeeding without specialist advice, as safety has not been established. Do not start or stop it without your doctor's guidance.
সাধারণ প্রশ্ন
What kind of medicine is ROXOLYTE F.C TABLET and what is it used for?
It is an oral anticoagulant containing rivaroxaban. It is used in adults to help prevent harmful blood clots in conditions such as atrial fibrillation, after certain heart events, and in the treatment of deep vein thrombosis and pulmonary embolism. Your doctor will decide if it is right for you.
How should I take ROXOLYTE F.C TABLET?
Take it by mouth with water, with or without food, as your doctor advises. Swallow it whole. The doctor decides the dose and how long you need it. Do not change or stop the medicine on your own, because stopping suddenly can increase the risk of clots.
What does the dosage form and strength mean?
ROXOLYTE F.C TABLET is a film-coated tablet, meaning it has a thin coating to make it easier to swallow and protect it. The strength is 10 mg, which is the amount of rivaroxaban in each tablet. Your doctor will decide how many tablets you need.
Can I stop taking ROXOLYTE F.C TABLET on my own?
No. Stopping this medicine early without another anticoagulant can raise the risk of blood clots. Always talk to your doctor before stopping or changing it, even if you feel well. Your doctor will tell you how and when to stop safely if needed.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
- For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:- The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
- Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
- Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
- Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
- Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
- Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.বিকল্প ব্র্যান্ড: Rivaroxaban
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।